Cancer treatment turbocharges patients’ own blood cells to kill solid tumours for first time

A LIVING cancer drug has been proven to work against solid tumours for the first time.

Immune-boosting CAR-T therapy removes a patient’s white blood cells and engineers them into highly specialised cancer killers in a lab.

Car-T cell therapy removes a patient’s blood cells and engineers them into specialised cancer killers (stock image)Getty

They are then injected back into the patient and let loose against the disease.

It is currently only used for blood cell...